Shares of Perrigo Company plc (NYSE:PRGO – Get Free Report) have been given a consensus rating of “Hold” by the six research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $19.3333.
A number of equities research analysts have recently commented on the stock. Wall Street Zen cut shares of Perrigo from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Zacks Research raised shares of Perrigo from a “strong sell” rating to a “hold” rating in a research note on Friday, February 13th. Jefferies Financial Group reaffirmed a “hold” rating on shares of Perrigo in a research note on Thursday. Weiss Ratings restated a “sell (d+)” rating on shares of Perrigo in a research report on Monday, December 22nd. Finally, Argus upgraded Perrigo to a “hold” rating in a research report on Wednesday, January 14th.
Get Our Latest Stock Report on Perrigo
Hedge Funds Weigh In On Perrigo
Perrigo Stock Down 4.8%
NYSE PRGO traded down $0.63 during trading on Monday, reaching $12.59. 1,435,604 shares of the company’s stock were exchanged, compared to its average volume of 2,616,653. The stock has a market cap of $1.73 billion, a P/E ratio of -1.23, a price-to-earnings-growth ratio of 1.30 and a beta of 0.41. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.63 and a current ratio of 2.76. Perrigo has a 1 year low of $12.17 and a 1 year high of $30.93. The company has a 50 day moving average price of $14.41 and a two-hundred day moving average price of $17.41.
Perrigo (NYSE:PRGO – Get Free Report) last announced its earnings results on Thursday, February 26th. The company reported $0.77 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.80 by ($0.03). The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. Perrigo had a negative net margin of 33.51% and a positive return on equity of 9.41%. The firm’s revenue for the quarter was down 2.5% compared to the same quarter last year. During the same period last year, the company earned $0.93 earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, equities research analysts anticipate that Perrigo will post 2.56 EPS for the current fiscal year.
Perrigo Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Investors of record on Monday, March 2nd will be paid a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 9.2%. The ex-dividend date is Monday, March 2nd. Perrigo’s dividend payout ratio is presently -11.28%.
About Perrigo
Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.
Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.
Featured Articles
- Five stocks we like better than Perrigo
- ATCX is Sitting on One of Brazil’s Largest Critical Minerals Portfolios!
- A Rockefeller Moment Is Unfolding in Rare Earths
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Half of America’s jobs gone in the next 12 months???
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.
